NASDAQ: LGVNLongeveron Inc Stock Ownership - Who owns Longeveron?
Insider buying vs selling
Have Longeveron Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Rock Soffer | Director | 2024-04-11 | 31,915 | $2.35 | $75.00kBuy |
| Mohamed Wael Ahmed Hashad | Chief Executive Officer | 2024-04-11 | 10,638 | $2.35 | $25.00kBuy |
| Joshua Hare | Chief Scientific Officer | 2024-04-11 | 42,553 | $2.35 | $100.00kBuy |
| Joshua Hare | Chief Scientific Officer | 2024-04-10 | 106,383 | $2.35 | $250.00kBuy |
| Rock Soffer | Director | 2024-04-10 | 106,383 | $2.35 | $250.00kBuy |
| Mohamed Wael Ahmed Hashad | Chief Executive Officer | 2024-03-12 | 32,866 | $0.54 | $17.75kSell |
| Cathy Ross | Director | 2024-01-10 | 5,000 | $1.31 | $6.55kBuy |
| Nataliya Agafonova | Chief Medical Officer | 2024-01-02 | 3,074 | $1.32 | $4.06kSell |
| Lisa Locklear | Chief Financial Officer | 2024-01-02 | 4,098 | $1.32 | $5.41kSell |
| Mohamed Wael Ahmed Hashad | Chief Executive Officer | 2024-01-02 | 5,123 | $1.32 | $6.76kSell |
LGVN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when LGVN insiders and whales buy or sell their stock.
LGVN Shareholders
What type of owners hold Longeveron Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Donald M. Soffer | 545.78% | 13,717,945 | $24.97M | Insider |
| Armistice Capital LLC | 73.05% | 1,836,000 | $3.34M | Institution |
| Joshua Hare | 27.32% | 686,794 | $1.25M | Insider |
| Rock Soffer | 8.30% | 208,534 | $379.53k | Insider |
| Vanguard Group Inc | 7.60% | 190,975 | $347.57k | Institution |
| Paul T. Lehr | 5.67% | 142,406 | $259.18k | Insider |
| Geoff Green | 5.33% | 133,904 | $243.71k | Insider |
| Blackrock Inc | 4.44% | 111,700 | $203.29k | Institution |
| Creative Planning | 4.35% | 109,322 | $198.97k | Institution |
| Geode Capital Management LLC | 3.59% | 90,238 | $164.23k | Institution |
LGVN vs Biotech Stocks
Longeveron Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.